Abstract | BACKGROUND: METHODS: 96 patients were randomly assigned treatment with chloroquine 25 mg/kg or pyronaridine 32 mg/kg, both orally and divided over 3 days. Patients were followed up for at least 14 days on an outpatient basis. Analysis was by on-active-treatment. FINDINGS: INTERPRETATION:
|
Authors | P Ringwald, J Bickii, L Basco |
Journal | Lancet (London, England)
(Lancet)
Vol. 347
Issue 8993
Pg. 24-8
(Jan 06 1996)
ISSN: 0140-6736 [Print] England |
PMID | 8531545
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antimalarials
- Naphthyridines
- Chloroquine
- pyronaridine
|
Topics |
- Administration, Oral
- Adolescent
- Adult
- Animals
- Antimalarials
(therapeutic use)
- Cameroon
- Chloroquine
(therapeutic use)
- Drug Resistance
- Female
- Follow-Up Studies
- Humans
- Malaria, Falciparum
(drug therapy, parasitology)
- Male
- Middle Aged
- Naphthyridines
(therapeutic use)
- Plasmodium falciparum
(drug effects)
- Treatment Outcome
|